Stifel Maintains Masimo(MASI.US) With Buy Rating, Maintains Target Price $170

斯迪富維持麥斯莫醫療(MASI.US)買入評級，維持目標價170美元

moomoo資訊 · 11/06 21:37 · 評級/大行評級

Stifel analyst Rick Wise maintains $Masimo (MASI.US)$ with a buy rating, and maintains the target price at $170.

According to TipRanks data, the analyst has a success rate of 57.9% and a total average return of 4.5% over the past year.

AnalystRecentRatingAutoNews_205777_20241106_5e77bd5b0cd08354f017802838aed2e670c417a8_1730957461852607_mm_en

Furthermore, according to the comprehensive report, the opinions of $Masimo (MASI.US)$'s main analysts recently are as follows:

The swift action taken by new management and the board to improve the company's profit and loss statement is viewed positively. With the support of robust consumables revenue growth and hospital contracting, it is anticipated that the company will exceed performance expectations in the fourth quarter and continue this trajectory into 2025.
Following the quarterly results, the focus is now on the year 2025, with expectations for at least a 26% operating margin for stand-alone healthcare, marking a 2% increase from prior projections. A strategic update is anticipated in January.

Note:

TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.

Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.

TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.

斯迪富分析師Rick Wise維持$麥斯莫醫療 (MASI.US)$買入評級，維持目標價170美元。

根據TipRanks數據顯示，該分析師近一年總勝率為57.9%，總平均回報率為4.5%。

AnalystRecentRatingAutoNews_205777_20241106_5e77bd5b0cd08354f017802838aed2e670c417a8_1730957461852607_mm_tc

此外，綜合報道，$麥斯莫醫療 (MASI.US)$近期主要分析師觀點如下：

新管理層和董事會爲改善公司的損益表而迅速採取的行動受到積極評價。在強勁的消耗品收入增長和醫院合同的支持下，預計該公司將在第四季度超出業績預期，並將這一軌跡延續到2025年。
根據季度業績，現在的重點是2025年，預計獨立醫療保健的營業利潤率至少爲26％，較先前的預測增長2％。預計將在一月份發佈戰略更新。

提示:

TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。

TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。

分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。

總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。更多信息

Stifel Maintains Masimo(MASI.US) With Buy Rating, Maintains Target Price $170

Stifel Maintains Masimo(MASI.US) With Buy Rating, Maintains Target Price $170

風險及免責聲明

聲明